0001209191-17-060277.txt : 20171113 0001209191-17-060277.hdr.sgml : 20171110 20171113161014 ACCESSION NUMBER: 0001209191-17-060277 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171109 FILED AS OF DATE: 20171113 DATE AS OF CHANGE: 20171113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Conroy Kevin T CENTRAL INDEX KEY: 0001306119 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35092 FILM NUMBER: 171195930 MAIL ADDRESS: STREET 1: 441 CHARMANY DRIVE CITY: MADISON STATE: WI ZIP: 53719 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EXACT SCIENCES CORP CENTRAL INDEX KEY: 0001124140 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 204782291 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 441 CHARMANY DRIVE CITY: MADISON STATE: WI ZIP: 53719 BUSINESS PHONE: 608-284-5700 MAIL ADDRESS: STREET 1: 441 CHARMANY DRIVE CITY: MADISON STATE: WI ZIP: 53719 FORMER COMPANY: FORMER CONFORMED NAME: EXACT CORP DATE OF NAME CHANGE: 20000919 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-11-09 0 0001124140 EXACT SCIENCES CORP EXAS 0001306119 Conroy Kevin T C/O EXACT SCIENCES CORP. 441 CHARMANY DRIVE MADISON WI 53719 1 1 0 0 President and CEO Common Stock 2017-11-09 4 M 0 137815 0.83 A 967867 D Common Stock 2017-11-09 4 S 0 51976 58.593 D 915891 D Common Stock 2017-11-09 4 S 0 80405 59.431 D 835486 D Common Stock 2017-11-09 4 S 0 5424 60.046 D 830052 D Common Stock 24990 I Held in 401(K) Account Common Stock 65189 I Held in Grantor Retained Annuity Trust Stock Option (right to buy) 0.83 2017-11-09 4 M 0 137815 0.00 D 2013-03-18 2019-03-18 Common Stock 137815 880261 D As previously announced by Exact Sciences Corporation in its Current Report on Form 8-K filed on August 11, 2017, the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2017 which covers only the remaining portion of a stock option granted to Mr. Conroy in March 2009 that expires in March 2019. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.93 to $58.92, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.93 to $59.92, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.93 to $60.36, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. In addition to the shares of Common Stock and options to purchase Common Stock reported on this Form 4, which total 1,800,492 shares, Mr. Conroy also holds, in the aggregate, an additional 1,125,158 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. /s/ Kevin T. Conroy by Mark R. Busch, attorney-in-fact 2017-11-13